Dublin, September 2011 – Taoiseach Enda Kenny announced that Pfizer, the world’s leading Biopharmaceutical Company, is to make a substantial investment of $200 million (€145m) at its Grange Castle biotechnology manufacturing facility in Clondalkin, Co. Dublin.

Pfizer is one of Ireland’s leading employers and the largest pharmaceutical companies.  Pfizer was one of the first pharmaceutical companies to locate in Ireland (1969), and has been constantly reinventing itself through innovation, investment and by pioneering new technology.  The business currently employs 4,300 staff across eight locations based in Cork, Dublin, Kildare and Limerick.
Grange Castle is where cutting-edge thinking in biopharmaceutical science combines with state-of-the-art technology and the production expertise it requires to make a real difference to people's lives.

Pfizer’s business interests in Ireland are diverse. There is a manufacturing presence in Active Pharmaceutical Ingredients, Solid Dose Pharmaceuticals, Nutritionals, Vaccines and Biopharmaceuticals; Global Financial Services centre and a global Treasury operation.


 



 

Newsletters Newsroom Suppliers and Services Directory